Table 3.
Emphysema | GGOa | Reticular | Micronodules | Bronchiectasis | Nodulesb | |
---|---|---|---|---|---|---|
Standard dose | ||||||
Apex level | 0.70 ± 1.20 | 1.14 ± 1.35 | 1.63 ± 1.47 | 0.76 ± 1.30 | 0.79 ± 1.31 | 0.49 ± 1.11 |
Aortic arch level | 0.64 ± 1.17 | 1.21 ± 1.42 | 1.45 ± 1.49 | 0.92 ± 1.38 | 1.10 ± 1.41 | 0.59 ± 1.19 |
Carina level | 0.58 ± 1.15 | 1.91 ± 1.40 | 1.89 ± 1.43 | 1.05 ± 1.41 | 1.25 ± 1.44 | 0.81 ± 1.34 |
Inferior PV level | 0.93 ± 1.35 | 2.05 ± 1.35 | 2.01 ± 1.37 | 0.66 ± 1.20 | 1.28 ± 1.46 | 0.90 ± 1.38 |
Hepatic vein level | 0.72 ± 1.23 | 1.89 ± 1.37 | 1.77 ± 1.43 | 0.64 ± 1.18 | 0.81 ± 1.31 | 0.41 ± 1.03 |
Low dose | ||||||
Apex level | 0.86 ± 1.36 | 1.09 ± 1.32 | 1.68 ± 1.50 | 0.99 ± 1.49 | 0.80 ± 1.32 | 0.60 ± 1.23 |
Aortic arch level | 0.73 ± 1.29 | 1.18 ± 1.40 | 1.48 ± 1.49 | 1.05 ± 1.46 | 1.13 ± 1.43 | 0.51 ± 1.08 |
Carina level | 0.72 ± 1.33 | 1.94 ± 1.40 | 1.97 ± 1.42 | 1.06 ± 1.41 | 1.40 ± 1.51 | 0.81 ± 1.34 |
Inferior PV level | 1.12 ± 1.48 | 2.19 ± 1.32 | 2.06 ± 1.36 | 0.84 ± 1.40 | 1.43 ± 1.50 | 0.84 ± 1.32 |
Hepatic vein level | 0.92 ± 1.42 | 2.07 ± 1.37 | 1.69 ± 1.44 | 0.72 ± 1.29 | 1.36 ± 3.97 | 0.50 ± 1.16 |
p-valuec | ||||||
Apex level | 0.312 | 0.908 | 0.705 | 0.151 | 0.957 | 0.463 |
Aortic arch level | 0.762 | 0.758 | 0.810 | 0.426 | 0.854 | 0.637 |
Carina level | 0.386 | 0.836 | 0.603 | 0.997 | 0.393 | 1.000 |
Inferior PV level | 0.314 | 0.279 | 0.649 | 0.268 | 0.321 | 0.684 |
Hepatic vein level | 0.299 | 0.201 | 0.565 | 0.649 | 0.082 | 0.530 |
The score deviation of a reader is defined as the reader’s score (low dose CT or standard dose CT) minus mean of the standard dose CT scores by the two other readers.
GGO, ground-glass opacity.
Nodules measuring >5 mm.
Wilcoxon signed rank test.